Promoter Hypermethylation and Underexpression of Patched Homolog 1 in Pancreatic and Colorectal Cancers: A Cross-Sectional Study

CONCLUSION Our results indicate that epigenetic silencing of the PTCH1 promoter and concomitant loss of PTCH1 protein expression may play an important role in the development and progression of these cancers.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:OBJECTIVE Patched homolog 1 (PTCH1) - a trans-membrane protein is a tumor suppressor which negatively regulates Hedgehog signaling pathway.

📊

Temel Bulgular & Veri:The present study aimed to investigate the promoter hypermethylation and protein expression pattern of PTCH1 in Pancreatic cancer (PC) and Colorectal cancer (CRC).

💡

Sonuç & Katkı:CONCLUSION Our results indicate that epigenetic silencing of the PTCH1 promoter and concomitant loss of PTCH1 protein expression may play an important role in the development and progression of these cancers.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE Patched homolog 1 (PTCH1) - a trans-membrane protein is a tumor suppressor which negatively regulates Hedgehog signaling pathway. The present study aimed to investigate the promoter hypermethylation and protein expression pattern of PTCH1 in Pancreatic cancer (PC) and Colorectal cancer (CRC). METHODS Promoter hypermethylation of PTCH1 gene was analyzed using Methylation-Specific Polymerase Chain Reaction and protein expression pattern was studied using western blotting. RESULTS Promoter hypermethylation of the PTCH1 gene was found in 42.42% (14/33) and 55.73% (34/61) of Pancreatic and Colorectal tumor samples, respectively. A significant correlation was found between PTCH1 hypermethylation and smoking status in PC while PTCH1 hypermethylation in CRC was significantly correlated with late-stage disease and lymph node metastasis. PTCH1 protein was under expressed in 30.3% (10/33) and 50.8 % (31/61) of Pancreatic and Colorectal tumor samples, respectively. Methylation analysis of PTCH1 in Pancreatic adenocarcinoma cell line 1 (PANC-1) and Colorectal adenocarcinoma cell line (HT-29) revealed hemi methylation in PANC-1, complete methylation in HT-29 and methylation was clearly associated with loss of expression. CONCLUSION Our results indicate that epigenetic silencing of the PTCH1 promoter and concomitant loss of PTCH1 protein expression may play an important role in the development and progression of these cancers.

🔖

Bu Makaleye Atıf Yap

WANI, R. A., NIYAZ, M., KHAN, M. S., MUDASSAR, S., SHAH, A., SHAH, O. J., BESINA, S. (2022). Promoter Hypermethylation and Underexpression of Patched Homolog 1 in Pancreatic and Colorectal Cancers: A Cross-Sectional Study. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 4, 478–488. https://ajindex.com/articles/655150

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006;5:1026– 33
Varjosalo M, Taipale J. Hedgehog signaling. J Cell Sci 2007;120:3–6
Ingham PW, Nakano Y, Seger C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet 2011;12:393–406
Lee RT, Zhao Z, Ingham PW. Hedgehog signalling. Dev Camb Engl 2016;143:367–72
Barakat MT, Humke EW, Scott MP. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med 2010;16:337–48
Sadikovic B, Al-Romaih K, Squire J, Zielenska M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics 2008;9:394–408
Pak E, Segal RA. Hedgehog signal transduction: Key players, oncogenic drivers, and cancer therapy. Dev Cell 2016;38:333–44
Hsia EY, Gui Y, Zheng X. Regulation of Hedgehog signaling by ubiquitination. Front Biol 2015;10:203–20
Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutiérrez García-Rodrigo C, Fargnoli MC.Understanding the molecular genetics of basal cell carcinoma. Int J Mol Sci 2017;18:2485. 10.Zuo Y, Song Y. Detection and analysis of the methylation status of PTCH1 gene involved in the hedgehog signaling pathway in a human gastric cancer cell line. Exp Ther Med 2013;6:1365–8. 11.Pandith AA, Siddiqi MA. Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario. Tumour Biol 2012;33:1629–37. 12.Sproul D, Meehan RR. Genomic insights into cancerassociated aberrant CpG island hypermethylation. Brief Funct Genomics 2013;12:174–90. 13.Varjosalo M, Taipale J. Hedgehog: Functions and mechanisms. Genes Dev 2008;22:2454–72. 14.Peng L, Hu J, Li S, Wang Z, Xia B, Jiang B, et al. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci. Int J Cancer 2013;132:E18–25. 15.Cretnik M, Musani V, Oreskovic S, Leovic D, Levanat S. The patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med 2007;19:875–83. 16.Chakraborty C, Dutta S, Mukherjee N, Samadder S, Roychowdhury A, Roy A, et al. Inactivation of PTCH1 is associated with the development of cervical carcinoma: Clinical and prognostic implication. Tumour Biol 2015;36:1143–54. 17.Lee KW, Pausova Z. Cigarette smoking and DNA methylation. Front Genet 2013;4:1–11. 18.Ishiyama A, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, et al. PTCH gene expression as a potential marker fo